Related Experiment Video
Updated: Dec 12, 2025
05:26
A Standardized Liquid Biopsy Preanalytical Protocol for Downstream Circulating-Free DNA Applications
Published on: September 16, 2022
4.4K
Liquid Biopsy: A Biomarker-Driven Tool towards Precision Oncology
Nelson S Yee1,2,3
1Division of Hematology-Oncology, Department of Medicine, Penn State Health Milton S. Hershey Medical Center, Hershey, PA 17033-0850, USA.
Journal of Clinical Medicine
|August 14, 2020
Summary
Liquid biopsy, a minimally invasive technique analyzing bodily fluids like blood, shows significant promise in clinical medicine, particularly for cancer detection and monitoring. This approach offers a non-invasive alternative to traditional tissue biopsies for various medical applications.
Area of Science:
- Biomedical Science
- Oncology
- Molecular Diagnostics
Background:
- Liquid biopsy involves analyzing biological fluids, primarily blood, for diagnostic and monitoring purposes.
- Intensive research is underway to establish its clinical utility, especially in oncology.
Discussion:
- The potential of liquid biopsy extends beyond oncology to various medical fields.
- Further development is crucial for widespread clinical adoption and validation.
Key Insights:
- Liquid biopsy offers a less invasive method for obtaining critical patient information.
- Its applications are rapidly expanding due to technological advancements.
Outlook:
- Continued research aims to refine liquid biopsy techniques for improved sensitivity and specificity.
- This technology is poised to revolutionize personalized medicine and cancer care.
